RRM1 single nucleotide polymorphism -37C→A correlates with progression-free survival in NSCLC patients after gemcitabine-based chemotherapy

BACKGROUND: The ribonucleotide reductase M1 (RRM1) gene encodes the regulatory subunit of ribonucleotide reductase, the molecular target of gemcitabine. The overexpression of RRM1 mRNA in tumor tissues is reported to be associated with gemcitabine resistance. Thus, single nucleotide polymorphisms (S...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Song, Guo, Ai-Lin, Chen, Zhi-Hong, Wang, Zhen, Zhang, Xu-Chao, Huang, Ying, Xie, Zhi, Yan, Hong-Hong, Cheng, Hua, Wu, Yi-Long
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2855513/
https://www.ncbi.nlm.nih.gov/pubmed/20226083
http://dx.doi.org/10.1186/1756-8722-3-10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2855513/
https://www.ncbi.nlm.nih.gov/pubmed/20226083
http://dx.doi.org/10.1186/1756-8722-3-10

Ejemplares similares